-Charles J Yeo Researcher Activity Profile

Research Author Detailed Information 

Charles J Yeo Publication Rate By Year

Charles J Yeo has published 1 paper(s) in 2002, 1 paper(s) in 2004, 2 paper(s) in 2006, 13 paper(s) in 2007, 5 paper(s) in 2008, for a total of 22 research publications in total.

Charles J Cj Yeo Author Information

LAST NAME: yeo

FIRST NAME: Charles J

INITIALS: cj

AFFILIATION:

Papers

Charles J Yeo's Publication Record

1. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Year Published: 2007
Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD 22187-6681, USA. tpawlik1@jhmi.edu
2. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Year Published: 2002
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
3. Diagnostic and treatment modalities for autoimmune pancreatitis. Year Published: 2006
Thomas Jefferson University, 1100 Walnut Street, 5th Floor, Philadelphia, PA 19107, USA. Charles.Yeo@jefferson.edu.
4. MKK4 status predicts survival after resection of gastric adenocarcinoma. Year Published: 2006
Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21231-1000, USA.
5. Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. Year Published: 2007
Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
6. Gangliocytic paraganglioma: case report and review of the literature. Year Published: 2007
Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.
7. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. Year Published: 2007
Department of Oncology, The Johns Hopkins University, Baltimore, MD, USA.
8. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Year Published: 2007
Department of Surgery and Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA. maxschmi@iupui.edu
9. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Year Published: 2007
Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, Germany.
10. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia. Year Published: 2007
1Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
11. Gangliocytic paraganglioma: case report and review of the literature. Year Published: 2007
Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.
12. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Year Published: 2007
Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, Germany.
13. Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. Year Published: 2007
Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
14. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Year Published: 2007
Department of Surgery and Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA. maxschmi@iupui.edu
15. SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients. Year Published: 2008
Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts.
16. Angiotensin II Induces Vascular Endothelial Growth Factor in Pancreatic Cancer Cells Through an Angiotensin II Type 1 Receptor and ERK1/2 Signaling. Year Published: 2008
Department of Surgery, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA, USA, hwyda.arafat@jefferson.edu.
17. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Year Published: 2004
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA.
18. Pancreatic VIPomas: Subject Review and One Institutional Experience. Year Published: 2008
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
19. Duodenojejunostomy leaks after pancreaticoduodenectomy. Year Published: 2008
Department of Surgery, Johns Hopkins Medical Institutions, Blalock 679, 600 N. Wolfe St., Baltimore, MD, 21287, USA, jcameron@jhmi.edu.
20. SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients. Year Published: 2008
Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts, USA.
21. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia. Year Published: 2007
Department of Surgery, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107, USA. jonathan.brody@jefferson.edu
22. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia. Year Published: 2007
Department of Surgery, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107, USA. jonathan.brody@jefferson.edu